Physician profile
Kirk E Maes
NPI 1609818343
$1,322.65
in general payments reported to CMS, 2019-2025
11 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $15.16 · 2022: $33.00 · 2023: $278 · 2024: $395 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $891.62 | 2022-2025 | Gamma, Triathlon, Mako |
| Ermi LLC | $92.17 | 2024 | |
| Smith+Nephew, INC. | $87.83 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Djo, LLC | $57.50 | 2025 | Procare |
| Radius Health, INC. | $54.46 | 2019 | |
| Amgen INC. | $32.40 | 2019-2025 | Evenity |
| Medacta USA, INC. | $29.64 | 2019 | |
| Orthogenrx INC. | $22.27 | 2019 | |
| Endo Pharmaceuticals INC. | $22.22 | 2019 | |
| Orthofix Medical, INC. | $17.38 | 2019 | |
| Encore Medical, LP | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Maes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.